STOCK TITAN

Astrotech (ASTC) posts Q3 2026 revenue of $343K and $3.8M net loss

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Astrotech Corporation reported third-quarter fiscal 2026 results for the period ended March 31, 2026. Revenue for the quarter was $343 thousand compared with $534 thousand a year earlier, generating gross profit of $67 thousand. Operating expenses were $3.52 million, leading to a loss from operations of $3.45 million and a quarterly net loss of $3.77 million, versus $3.63 million in the prior-year quarter.

For the nine months ended March 31, 2026, revenue totaled $787 thousand and net loss was $11.16 million. Cash and cash equivalents were $2.68 million and short-term investments were $3.90 million as of March 31, 2026. Total assets were $16.17 million and total stockholders’ equity was $12.16 million, with an accumulated deficit of $262.03 million. Management highlighted continued cost-efficiency efforts while investing selectively in higher-return areas and advancing a sales pipeline across industrial, safety and trace detection markets.

Positive

  • None.

Negative

  • None.

Insights

Astrotech reports modest revenue with continued operating losses and a smaller balance sheet.

Astrotech generated quarterly revenue of $343 thousand, with gross profit of $67 thousand against operating expenses of $3.52 million, resulting in a net loss of $3.77 million. For the nine-month period, net loss reached $11.16 million.

The balance sheet at March 31, 2026 shows cash of $2.68 million, short-term investments of $3.90 million, total assets of $16.17 million and stockholders’ equity of $12.16 million. This is down from $26.99 million in assets and $22.10 million in equity at June 30, 2025.

Management emphasizes cost-efficiency initiatives and selective investment in higher-return areas while pursuing a sales pipeline for its mass spectrometry-based products. Future disclosures in periodic reports will indicate whether expense control and commercialization efforts translate into improved revenue and reduced losses.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q3 2026 revenue $343 thousand Three months ended March 31, 2026
Q3 2025 revenue $534 thousand Three months ended March 31, 2025
Q3 2026 net loss $3.77 million Three months ended March 31, 2026
Nine-month 2026 net loss $11.16 million Nine months ended March 31, 2026
Cash and cash equivalents $2.68 million As of March 31, 2026
Short-term investments $3.90 million As of March 31, 2026
Total assets $16.17 million As of March 31, 2026
Accumulated deficit $262.03 million As of March 31, 2026
forward-looking statements regulatory
"This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
available-for-sale securities financial
"Available-for-sale securities: Net unrealized gain (loss)"
Available-for-sale securities are investments in stocks, bonds or similar instruments that a company does not intend to trade frequently but may sell before they mature. They matter to investors because changes in the market value of these holdings show up as paper gains or losses on the company's balance sheet rather than immediately in profit, so they can affect reported net worth and the timing of income without changing day-to-day earnings. Think of them like items on a household shelf you might sell later: their value moves with the market even if you haven’t cashed out.
accumulated other comprehensive loss financial
"Accumulated other comprehensive loss | | | (389 | )"
Accumulated other comprehensive loss is the running negative total of certain gains and losses that companies record outside their regular profit-and-loss statement, such as changes in the value of some investments, pension adjustments, or currency translation effects. It matters to investors because it reduces shareholders’ equity and reveals economic swings that haven’t affected reported net income yet — like a side ledger showing pending ups and downs that could influence future cash flow or balance-sheet strength.
operating lease right-of-use assets financial
"Operating lease right-of-use assets, net | | | 1,906"
An operating lease right-of-use (ROU) asset is an accounting entry that shows the value of a leased item you have the legal right to use—like a building, vehicle, or equipment—recorded on a company’s balance sheet along with the corresponding lease obligation. Investors care because it adds to reported assets and liabilities, changing measures like leverage and return on assets much like bringing a long-term rental onto the company’s financial snapshot, which can affect credit terms and valuation.
additional paid-in capital financial
"Additional paid-in capital | | | 84,050"
Amount of money shareholders have paid to a company for shares that is above the stock’s nominal or par value; think of it as the extra premium paid when a group buys a ticket that has a low listed price. It matters to investors because it represents permanent capital on the balance sheet that can cushion losses, affect book value per share and indicate how much fresh cash equity holders have contributed beyond the minimum share value.
Revenue $343 thousand
Net loss $3.77 million
Nine-month revenue $787 thousand
Nine-month net loss $11.16 million
false 0001001907 0001001907 2026-05-13 2026-05-13
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): May 13, 2026
 
 
logo.jpg
 
Astrotech Corporation
 
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware
 
001-34426
 
91-1273737
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
   
1817 W. Braker Lane, Suite 400, Austin, Texas
 
78758
(Address of Principal Executive Offices)
 
(Zip Code)
 
(512) 485-9530
 
Registrants Telephone Number, Including Area Code
 
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
 
 
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
 
 
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.001 par value per share
 
ASTC
 
NASDAQ Stock Market, LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02. Results of Operations and Financial Condition.
 
On May 13, 2026, Astrotech Corporation (the “Company”) issued a press release announcing its results of operations for its third quarter of fiscal year 2026, which ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
 
The information in this Current Report on Form 8-K, including Exhibit 99.1 furnished hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth in such filing.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit No.
Description
99.1
Press Release, dated May 13, 2026, issued by Astrotech Corporation.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Astrotech Corporation
 
       
May 13, 2026
By:
/s/ Thomas B. Pickens III
 
   
Thomas B. Pickens III
 
   
Chief Executive Officer, Chief Technology Officer and Chairman of the Board
(Principal Executive Officer and Principal Financial Officer)
 
 
 
 

Exhibit 99.1

 

 

logo.jpg

 

 

Astrotech Reports Third Quarter of Fiscal Year 2026 Financial Results

 

 

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2026, which ended March 31, 2026.

 

Financial Highlights & Recent Developments

 

 

Research and development expense was $554 thousand, a decline of 28% from the third quarter of fiscal year 2026 as the Company transitions from development stage to saleable products for its EN-SCAN Handheld GC and 1st Detect TRACER 1000 product lines.

 

 

Through March 31, 2026, the Company has deployed the TRACER 1000 trace detection system in approximately 37 locations in 16 countries across the United States, Europe and Asia.

 

“During the third quarter of fiscal year 2026, we remained focused on disciplined execution, achieving targeted cost-efficiency initiatives while continuing to invest selectively in the highest-return areas of the business. As a result, we are better positioned to operate efficiently in a dynamic macro environment. At the same time, our sales team is advancing a healthy sales pipeline supported by strong lead generation and ongoing customer engagement across key markets. Our deployments to date support these efforts with real-world demonstration of our solution capabilities and compelling data affirming the unique benefits of mass spectrometry technology in industrial, safety and trace detection applications. Looking ahead, we will continue to balance rigorous expense control with strategic investments to help convert pipeline opportunities into revenue growth”, said Thomas B. Pickens, III, Astrotech’s Chairman and Chief Executive Officer.

 

About Astrotech Corporation

 

Astrotech Corporation (Nasdaq: ASTC) is an instrumentation company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:

 

 

1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening.

 

AgLAB designs process analyzers tailored to the processing of agriculture products.

 

Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing.

 

EN-SCAN, Inc. delivers portable, ruggedized environmental GC-MS for on-site testing of air, water and soil.

 

Astrotech is headquartered in Austin, Texas. For more information, visit www.astrotechcorp.com

 

 

 

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” “contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These factors include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

 

 

Company Contact: 

Scott Bartley

Interim Chief Financial Officer, Astrotech Corporation

(512) 485-9530

 

Investor Contact: 

Matt Kreps

Managing Director, Darrow Associates

(214) 597-8200 mkreps@darrowir.com

 

Financial tables follow

 

 

 

 

ASTROTECH CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except per share data)

(Unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

March 31,

   

March 31,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $ 343     $ 534     $ 787     $ 829  

Cost of revenue

    276       297       525       428  

Gross profit

    67       237       262       401  

Operating expenses:

                               

Selling, general and administrative

    2,085       2,115       5,941       5,842  

Research and development

    1,435       1,989       5,211       6,375  

Total operating expenses

    3,520       4,104       11,152       12,217  

Loss from operations

    (3,453 )     (3,867 )     (10,890 )     (11,816 )

Other income and expense, net

    (315 )     234       (271 )     896  

Loss from operations before income taxes

    (3,768 )     (3,633 )     (11,161 )     (10,920 )

Net loss

  $ (3,768 )   $ (3,633 )   $ (11,161 )   $ (10,920 )

Weighted average common shares outstanding:

                               

Basic and diluted

    1,677       1,665       1,676       1,663  

Basic and diluted net loss per common share:

                               

Net loss per common share

  $ (2.25 )   $ (2.18 )   $ (6.66 )   $ (6.57 )

Other comprehensive loss, net of tax:

                               

Net loss

  $ (3,768 )   $ (3,633 )   $ (11,161 )   $ (10,920 )

Available-for-sale securities:

                               

Net unrealized gain (loss)

    159       139       476       236  

Total comprehensive loss

  $ (3,609 )   $ (3,494 )   $ (10,685 )   $ (10,684 )

 

 

 

 

ASTROTECH CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

 

   

March 31,

   

June 30,

 
   

2026

   

2025

 
   

(Unaudited)

   

(Note)

 

Assets

               

Current assets

               

Cash and cash equivalents

  $ 2,679     $ 3,100  

Short-term investments

    3,903       15,108  

Accounts receivable

    504       485  

Inventory, net:

               

Raw materials

    3,019       2,194  

Work-in-process

    531       425  

Finished goods

    310       310  

Prepaid expenses and other current assets

    383       353  

Total current assets

    11,329       21,975  

Property and equipment, net

    2,573       2,395  

Intangible asset, net

    50       48  

Operating lease right-of-use assets, net

    1,906       2,225  

Other assets, net

    315       346  

Total assets

  $ 16,173     $ 26,989  

Liabilities and stockholders equity

               

Current liabilities

               

Accounts payable

  $ 234     $ 1,066  

Payroll related accruals

    461       529  

Accrued expenses and other liabilities

    865       451  

Lease liabilities, current

    275       405  

Total current liabilities

    1,835       2,451  

Accrued expenses and other liabilities, net of current portion

    79       164  

Lease liabilities, net of current portion

    2,104       2,274  

Total liabilities

    4,018       4,889  

Commitments and contingencies (Note 14)

               

Stockholders equity

               

Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at March 31, 2026, and June 30, 2025

           

Common stock, $0.001 par value, 250,000,000 shares authorized at March 31, 2026, and June 30, 2025, respectively; 1,769,269 shares issued at March 31, 2026, and June 30, 2025 respectively; 1,758,953 shares outstanding at March 31, 2026, and June 30, 2025.

    190,643       190,643  

Treasury shares, 10,316 at March 31, 2026, and June 30, 2025, respectively

    (119 )     (119 )

Additional paid-in capital

    84,050       83,310  

Accumulated deficit

    (262,030 )     (250,870 )

Accumulated other comprehensive loss

    (389 )     (864 )

Total stockholders equity

    12,155       22,100  

Total liabilities and stockholders equity

  $ 16,173     $ 26,989  

 

Note: The balance sheet at June 30, 2025 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by the United States generally accepted accounting principles for complete financial statements.

 

 

FAQ

How much revenue did Astrotech (ASTC) report for Q3 fiscal 2026?

Astrotech reported $343 thousand in revenue for its third quarter of fiscal 2026, which ended March 31, 2026. This compares with $534 thousand in the same quarter of fiscal 2025, based on the company’s condensed consolidated statements.

What was Astrotech’s net loss for Q3 fiscal 2026?

Astrotech recorded a net loss of $3.77 million for the third quarter of fiscal 2026. In the prior-year quarter, the company reported a net loss of $3.63 million, reflecting continued operating losses despite cost-control efforts.

What were Astrotech’s nine-month fiscal 2026 results through March 31, 2026?

For the nine months ended March 31, 2026, Astrotech reported $787 thousand in revenue and a net loss of $11.16 million. Over the same period in fiscal 2025, revenue was $829 thousand and net loss was $10.92 million, according to the financial tables.

What does Astrotech’s balance sheet look like as of March 31, 2026?

As of March 31, 2026, Astrotech reported $2.68 million in cash and cash equivalents, $3.90 million in short-term investments, and $16.17 million in total assets. Total stockholders’ equity was $12.16 million, down from $22.10 million at June 30, 2025.

What strategic focus did Astrotech’s management highlight in the Q3 2026 results release?

Management emphasized disciplined execution and cost-efficiency initiatives while continuing to invest in the highest-return areas of the business. They also highlighted a healthy sales pipeline and deployments that demonstrate the benefits of the company’s mass spectrometry technology in industrial, safety and trace detection markets.

How many shares were used to calculate Astrotech’s Q3 2026 loss per share?

Astrotech used a weighted average of 1,677 thousand basic and diluted shares outstanding to calculate net loss per common share for the third quarter of fiscal 2026. The resulting basic and diluted net loss per share was $2.25 for the quarter.

Filing Exhibits & Attachments

5 documents